Top Tweets for #PHART2

about 2 years ago

2nd RCT showing #hypoRT 🟰 conv RT for high risk #ProstateCa @DrPatCheung #PHART2 RCT (PA @r_glicksman) was 1st: https://t.co/fIPFJNHBpO Now Q is the role of UHRT. Many trials accruing: @CDNCancerTrials #PR24 @VedangMurthy #PRIME @DrSuneil_PCa #PACE-NODES @NRGonc #GU013

Sean Collins Prostate SBRT @ USF Health @SbrtSean

about 2 years ago

Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate … https://t.co/K7Nc3Zpkis

Dr. Andrew Loblaw @DrAndrewLoblaw

over 3 years ago

I was hoping for efficacy results (or at least PSARR @4y)… @niazi_Dr7 when do plan to cut those data? @DrCorreaRO and @DrPatCheung have analyzed @Sunnybrook #PHART2 RCT (same design, n=178). mFU 64 mo - efficacy and toxicity will be reported. Stay tuned!

Gustavo

@gusviani

over 3 years ago

🗣️ Ph III trial HF 68Gy/25 vs standard fractionated (SF) 76Gy/38 HR #prostatecancer both arms pelvic RT+ADT ▶️329👥: 164 HF vs 164 SF 🔑Results 👉⬇️acute GI in HF (p=0.016), but not sig at 8 weeks 👉 NO# acute GU 👉At 24 mo: 🟰 GI tox but ⬇️ GU HF 👉⬇️ G3 tox/NOG4 #radonc

$gusviani's tweet photo. 🗣️ Ph III trial HF 68Gy/25 vs standard fractionated (SF) 76Gy/38 HR #prostatecancer both arms pelvic RT+ADT ▶️329👥: 164 HF vs 164 SF 🔑Results 👉⬇️acute GI in HF (p=0.016), but not sig at 8 weeks 👉 NO# acute GU 👉At 24 mo: 🟰 GI tox but ⬇️ GU HF 👉⬇️ G3 tox/NOG4 #radonc https://t.co/UL2NHjX318$

Dr. Andrew Loblaw @DrAndrewLoblaw

over 3 years ago

We plan to compare #SATURN and #5STAR (#SBRT to pelvis and prostate) with moderate hypofx (25fx to pelvis/prostate) and conventional RT (latter two as part of @DrPatCheung #PHART2 RCT)

Amar Kishan @AmarUKishan

over 3 years ago

@jfcdrr @EvanThomas84 @the_RSS @marslain SBRT is an acceptable option for HR and VHR per NCCN. For high risk, it says “nodal radiation should be considered” but does not comment on fractionation. @DrAndrewLoblaw @VedangMurthy @DrDarrenPoon Good published data for 25/5

Dr. Andrew Loblaw @DrAndrewLoblaw

over 4 years ago

@VedangMurthy @AmarUKishan @achoud72 @Sushilberiwal @RTendulkarMD @docpriyamvada @indranilsays @DrSrinivas_C @AbhiG_RadOnc @RadOncTMC @Sunnybrook we allowed 25/5 concomitantly with 40/5 (#SATURN technique) when Covid-19 hit. Probably have treated about 200 pts weekly or more commonly EOD. Used about as often than our moderate hypofx protocol #PHART2 developed by @DrPatCheung

Dr. Andrew Loblaw @DrAndrewLoblaw

about 5 years ago

Expertly written by @r_glicksman ! Looking forward to seeing PHART2 RCT results and a comparison b/w #PHART2 and #SATURN

Rachel Glicksman @r_glicksman

about 5 years ago

Long term (>10y) data from pHART2- moderately hypofrac prostate boost with ENI +ADT for high risk disease. 10y BCF 33%, DM 16%, OS 76%. 5y toxicity and patient reported QoL. PI: P Cheung. @DrAndrewLoblaw @gerard_morton @dr_vesi @DrStanLiu @Sunnybrook https://t.co/8IwnVXToBS

Dr. Andrew Loblaw @DrAndrewLoblaw

about 7 years ago

Our usual is also SIB: 68/25 to prostate and 48/25 to nodes a la #WhereIsPatrickCheung #PHART2

Piet Ost @piet_ost

about 7 years ago · Ghent

@merino_tomas @DrAndrewLoblaw @PCaParker @nickva1 @_ShankarSiva @DrewMoghanaki @DrSuneil_PCa @AmarUKishan @PBlanchardMD We do 65 in 25 as a SIB.

Top Tweets for #PHART2

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users